Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-07-22
2008-07-22
McKane, Joeseph (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S233200, C514S229500, C514S397000, C514S422000, C514S254110, C544S099000, C544S111000, C544S060000, C546S198000, C548S311700, C548S421000
Reexamination Certificate
active
07402579
ABSTRACT:
The present invention relates to quinobenzoxazines analogs having the general formula:and pharmaceutically acceptable salts, esters and prodrugs thereof;wherein A, U, W, X, Z, B, L, R1, R3, R4and R5are substituents.The present invention also relates to methods for using such compounds.
REFERENCES:
patent: 5624924 (1997-04-01), Chu et al.
patent: 2004/0029882 (2004-02-01), Ledoussal et al.
patent: 2005/0004160 (2005-01-01), Whitten et al.
patent: WO 2004/091504 (2004-10-01), None
Han et al., Trends Pharm. Sci. (2000) 21:136-142.
International Search Report and Written Opinion for PCT/US2006/014212, mailed Jul. 20, 2007, 8 pages.
Pierre Fabrice
Schwaebe Michael
Whitten Jeffrey P.
Chu Yong
Cylene Pharmaceuticals, Inc.
McKane Joeseph
Morrison & Foerster / LLP
LandOfFree
Quinobenzoxazine analogs and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinobenzoxazine analogs and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinobenzoxazine analogs and compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2779037